Deutsche Bank Upgrades Mednax (MD) to Buy; Solid Entry Point for Steady Grower

Deutsche Bank upgraded Mednax (NYSE: MD) from Hold to Buy with a price target of $76.00.

Deutsche analyst says, "MD is one of those companies that we are always drawn to during a sector pull-back because it is well-run, well-capitalized and is a leader in outsourced physician markets that have reasonable long-term growth characteristics, yet lower overall risks. Ahead of Q3 and in front of what we expect to be a modest flurry of anesthesia transactions in the latter part of 2011, we believe investors have a solid entry point to Buy this steady grower."

For more ratings news on Mednax click here and for the rating history of Mednax click here.

Shares of Mednax closed at $62.98 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Deutsche Bank Upgrades Huizhou Desay Sv Automotive Co (002920:CH) to Hold
• TD Cowen Upgrades Northland Power Inc. (NPI:CN) (NPIFF) to Buy
• HSBC Upgrades Digital Realty Trust (DLR) to Buy